Vancomycin and ciprofloxacin: Systemic antibiotic administration for peritoneal dialysis-associated peritonitis

Peritoneal Dialysis International

Volumn 24, Issue 5, 2004, Pages 433-439

  Goffin, Eric ^a   Herbiet, Laurence ^a   Pouthier, Dominique ^b   Pochet, Jean Michel ^c   Lafontaine, Jean Jacques ^d   Christophe, Jean Louis ^d   Gigi, Jacques ^a   Vandercam, Bernard ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Centre Hospitalier   (Luxembourg)

^c Clinique & Maternite Sainte Elisabeth Namer   (Belgium)

^d Hopital St Joseph   (Belgium)

Author keywords

Ciprofloxacin; Mupirocin; Peritonitis; Rifampicin; Staphylococcus aureus; Vancomycin

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; METICILLIN; OXACILLIN; PIPERACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL PERITONITIS; BACTERIUM EXAMINATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DOSE RESPONSE; DRUG ERUPTION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PENICILLIN RESISTANCE; PERITONEAL DIALYSIS; PRESCRIPTION; PRIORITY JOURNAL; TENDON LESION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 7444231048     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080402400507     Document Type: Article

References (35)

1. Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998; 338:1428-37.
2. Gokal R, Mallick NP. Peritoneal dialysis. Lancet 1999; 353:823-8.
3. Combet S, Van Landschoot M, Moulin P, Piech A, Verbavatz JM, Goffin E, et al. Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol 1999; 10:2185-96.
4. Van Biesen W, Veys N, Vanholder R, Lameire N. Peritoneal-dialysis-related peritonitis: the art of rope-dancing. Nephrol Dial Transplant 2002; 17:1878-82.
5. Teitelbaum I. Vancomycin for the initial therapy of peritonitis: don't throw out the baby with the bath-water. Perit Dial Int 2001; 21:235-8.
6. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20: 828-9]. Perit Dial Int 2000; 20:396-411.
7. Hockensmith ML, Madinger NE, Teitelbaum I. Concerns regarding recommendations for the treatment of CAPD peritonitis. Perit Dial Int 2001; 21:317-19.
8. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999; 28:1062-6.
9. Hooper DC. Quinolones. In: Mandell GL, Benett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill-Livingstone; 1995: 364-76.
10. Goffin E, Pouthier D, Vandercam B, Gigi J. IV vancomycin-oral ciprofloxacin: a safe and efficient therapeutic protocol for CAPD peritonitis (preliminary report). Perit Dial Int 1996; 16:174-7.
11. Mulhern JG, Braden GL, O'Shea MH, Madden RL, Lipkowitz GS, Germain MJ. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients. Am J Kidney Dis 1995; 25:611-15.
12. Goldberg L, Clemenger M, Azadian B, Brown EA. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen. Am J Kidney Dis 2001; 37:49-55.
13. de Fijter CW, ter Wee PM, Oe LP, Verbrugh HA. Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER Trial). Perit Dial Int 2001; 21:480-6.
14. Tintillier M, Pochet JM, Christophe JL, Scheiff JM, Goffin E. Transient sterile chemical peritonitis with icodextrin: clinical presentation, prevalence, and literature review. Perit Dial Int 2002; 22:534-7.
15. Flanigan MJ, Lim VS. Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazolin. Perit Dial Int 1991; 11:31-7.
16. Gucek A, Bren AF, Lindic J, Hergouth V, Mlinsek D. Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients? Adv Perit Dial 1994; 10:144-6.
17. Alves FR, Dantas RC. Is the treatment of beta lactam sensitive infections without vancomycin possible [Abstract]? Perit Dial Int 1997; 17(Suppl 1):S27.
18. Khairullah Q, Provenzano R, Tayeb J, Ahmad A, Balakrishnan R, Morrison L. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients. Perit Dial Int 2002; 22: 339-44.
19. Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002; 22:573-81.
20. Vas S, Bargman J, Oreopoulos D. Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int 1997; 17:91-4.
21. Ariano RE, Franczuk C, Fine A, Harding GK, Zelenitsky SA. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients. Perit Dial Int 2002; 22:335-8.
22. Fielding RE, Clemenger M, Goldberg L, Brown EA. Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen. Perit Dial Int 2002; 22:345-9.
23. Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA. Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 1999; 34:14-20.
24. Williams JD, Coles GA. CAPD peritonitis. Int J Antimicrob Agents 1992; 1:165-74.
25. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EMC. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37: 1629-38.
26. Neu HC. Synergy of fluoroquinolones with other antimicrobial agents. Rev Infect Dis 1989; 11(Suppl 5): S1025-35.
27. Waite NM, Johnson MD, Webster NR, Fong IW. Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis. Perit Dial Int 1993; 13:50-4.
28. Fleming LW, Phillips G, Stewart WK, Scott AC. Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 25:441-8.
29. Baretti P, Bignardi JH, Soares VA. Successful treatment of peritonitis in IPD with oral fluoroquinolone. Perit Dial Int 1993; 13:192.
30. Hancock K, Hulme B. Treatment of CAPD peritonitis with oral fluoroquinolone. Nephrol Dial Transplant 1989; 8:759.
31. Nye KJ, Gibson SP, Nwosu AC, Manji MR, Robinson BH, Hawkins JB. Single-dose intraperitoneal vancomycin and oral ciprofloxacin for the treatment of peritonitis in CAPD patients: preliminary report. Perit Dial Int 1993; 13:59-60.
32. Wazny LD, Blake PG. Incompatibility of vancomycin and ceftazidime for intraperitoneal use. Perit Dial Int 2002; 22:93-4.
33. Obermiller LE, Tzamaloukas AH, Leymon P, Avasthi PS. Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis. Clin Nephrol 1985; 24:256-60.
34. Morse GD, Farolino DF, Apicella MA, Walshe JJ. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1987; 31:173-7.
35. Freiman JP, Graham DJ, Reed TG, McGoodwin EB. Chemical peritonitis following the intraperitoneal administration of vancomycin. Perit Dial Int 1992; 12: 57-60.